Amunix Pharmaceuticals, Inc.
Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.
4
Funding Rounds
$193.3m
Money raised
Overview
Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Vo**** Sc************ |
|
- |
Industries
Amunix Pharmaceuticals, Inc. is active in the following industries: